Ultragenyx is developing setrusumab in pediatric and young adult patients across OI sub-types I, III and IV with two late-stage studies: the pivotal Phase 2/3 Orbit study and Phase 3 Cosmic study.

Rights plan protects the Company and its stockholders from a change of control without a control premium. Amended and Restated Bylaws ensure orderly and informed consent solicitat ...

The new updates to the tech-infused broker-dealer include the incorporation of artificial intelligence (AI) and an automated ...

A practical founder's guide to ADA website compliance, covering tools, timelines, real costs, WCAG 2.1 AA standards and how ...

If your site is functional but forgettable, these seven UX fixes can help you boost engagement, reduce bounce and turn more ...

Looking to create a more professional online business? Learn how to build a Squarespace website in nine steps and get started today.

Abstract: This research addresses the imperative need for advanced detection mechanisms for the identification of phishing websites. For this purpose, we explore state-of-the-art machine learning, ...

The White House has declared war on “fake news” by creating a website to identify instances where it claims media outlets are misrepresenting the facts — with a “Hall of Shame” for repeat or egregious ...